Addyi, the drug many call "female Viagra," went on sale Saturday, NBC News reports. The FDA rejected Addyi twice — in 2010 and 2013 — before controversially issuing approval to the drug earlier this year.
Flibanserin, as it's known generically, will be prescribed to women to take once daily. Critics have argued the risks associated with the drug's side effects, like low blood pressure and dizziness, can be dangerous, and that the drug hasn't been tested extensively enough. They also say the so-called libido drug may not even be particularly effective for women looking to increase their sex drives.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
How will the next pope change the Catholic Church?Talking Points Conclaves can be unpredictable
-
Conspiracy theorists circle again following RFK file releaseThe Explainer Both RFK and his brother, President John F. Kennedy, have been the subjects of conspiracies
-
7 equestrian activities for when you feel like horsin' aroundThe Week Recommends These graceful animals make any experience better
-
Nobody seems surprised Wagner's Prigozhin died under suspicious circumstancesSpeed Read
-
Western mountain climbers allegedly left Pakistani porter to die on K2Speed Read
-
'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governorSpeed Read
-
Los Angeles city workers stage 1-day walkout over labor conditionsSpeed Read
-
Mega Millions jackpot climbs to an estimated $1.55 billionSpeed Read
-
Bangladesh dealing with worst dengue fever outbreak on recordSpeed Read
-
Glacial outburst flooding in Juneau destroys homesSpeed Read
-
Scotland seeking 'monster hunters' to search for fabled Loch Ness creatureSpeed Read
